课题基金 / 基金详情

Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain

Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain
基于人脑转录组分析的逆向工程分区特异性和年龄特异性 iPSC 衍生脑血管模型
批准号:
10321473
负责人:
Myriam Heiman
金额:
$83.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2023-08-31

项目摘要

项目成果

Myriam Heiman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Cerebrovascular dysfunction is emerging as a common pathology in many diseases of the brain, including neurodegenerative diseases, cerebrovascular diseases, as well as in aging. Therefore, understanding the role of cerebrovascular dysfunction in disease progression and aging will be key to long-term maintenance of brain health. With developments in tissue engineering and stem cell technology, in vitro cerebrovascular models can play an important role in understanding the role of cerebrovascular dysfunction in disease progression and aging. Next-generation cerebrovascular models should take into account three key factors: (1) differences in phenotype of brain microvascular endothelial cells along the arterio-venous axis, (intrinsic factors), (2) differences in microenvironmental cues along the arterio-venous axis (extrinsic factors), and (3) changes in zonation-specific cerebrovascular phenotype during aging and in response to aged serum. Therefore, the overall goal of this project is to use zonation- and age-specific intrinsic and extrinsic cues to reverse engineer human cerebrovascular models, and to use these models to understand cerebrovascular phenotype during aging. We will first perform a pooled genetic screen to identify transcription factor combinations that are capable of driving source cells towards gene expression profiles of human brain microvascular endothelial cells along the arterio-venous axis (Aim 1). Three candidate induced brain microvascular endothelial cells (iBMECs) for each zone will be generated using lentiviral transduction. The top candidate for each zone will then be selected from analysis of gene and protein expression profiles (Aim 2). We will then use the three iBMECs to demonstrate zonation-specific cerebrovascular phenotype in zonation-specific models (arteriole, capillary, venule) (Aim 3). Next, we will assess the influence of young and old serum on cerebrovascular phenotype in the zonation-specific models (Aim 4). Finally, we will use the same approach to create an aged cerebrovascular model in one zone. We will create iBMECs that match the transcription factor profile of human brain microvascular endothelial cells in the aged cerebrovasculature, and then assess the role of microenvironmental cues and young/old serum on cerebrovascular phenotype. This project is a collaboration between the Searson group (JHU) with expertise in tissue-engineered microvascular models, and the Heiman group (MIT) with expertise in genomics and molecular mechanisms of neurodegenerative disease. This project builds upon key recent accomplishments from the two labs: (1) the creation of a library of zonation-specific transcription factor profiles for brain microvascular endothelial cells from the human brain, (2) identification of key transcription factors to enable reverse engineering of zonation- specific human brain microvascular endothelial cells, and (3) tissue-engineered platforms for zonation-specific cerebrovascular models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease
Single-cell multi-region transcriptional and epigenomic dissection of VCID.
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
  • 批准号:
    10672447
  • 项目类别:
  • 资助金额:
    $243.39万
  • 财政年份:
    2021
  • 负责人:
    Myriam Heiman
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: